Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$25.86 - $46.71 $2.96 Million - $5.34 Million
114,300 Added 386.15%
143,900 $6.69 Million
Q1 2023

May 16, 2023

BUY
$26.05 - $32.31 $291,760 - $361,872
11,200 Added 60.87%
29,600 $848,000
Q4 2022

Feb 14, 2023

SELL
$19.77 - $42.23 $270,849 - $578,551
-13,700 Reduced 42.68%
18,400 $574,000
Q3 2022

Nov 14, 2022

SELL
$14.97 - $22.65 $74,850 - $113,250
-5,000 Reduced 13.48%
32,100 $651,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.